Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, et al. Eur Urol 2023 Aug 31:S0302-2838(23)03016-6. doi: 10.1016/j.eururo.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, et al. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Eur Urol 2023 Aug 31:S0302-2838(23)03016-6. doi: 10.1016/j.eururo.2023.
PMID: 37659962